- Mycophenolate mofetil in pediatric renal transplantationL T Weber
Division of Pediatric Nephrology, University Children s Hospital, Heidelberg, Germany
Minerva Urol Nefrol 55:91-9. 2003..Preliminary data demonstrate improved longitudinal growth, less cushingoid habitus and lower blood pressure after steroid-withdrawal in pediatric renal transplant recipients under MMF and CsA therapy...
- Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acidA Rother
Department of Paediatrics I, University Children s Hospital Heidelberg, Heidelberg, Germany
Eur J Clin Pharmacol 68:913-22. 2012..Since the field of pharmacodynamic monitoring of MPA is evolving, we also analyzed the response of IMPDH activity on MPA in children vs adolescents after renal transplantation...
- C2 monitoring and absorption profiling of cyclosporine for optimization of immunosuppressive therapy in pediatric renal transplant recipientsL T Weber
University Children's Hospital Heidelberg, Division of Paediatric Nephrology, Heidelberg, Germany
Transplant Proc 35:2128-30. 2003
- Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study GroupA Staskewitz
, Freiburg, Germany
Transplantation 71:638-44. 2001..One P developed PTLD 10 months after RTx and recovered after the reduction of immunosuppression. CONCLUSIONS: The combination of MMF, CyA, and Pred reduced ARE in pediatric RTx without incurring major side effects...